Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda A Hill

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the Neurological Sciences|May 14, 2026
Mortality associated with facioscapulohumeral muscular dystrophy: A systematic literature reviewKevin H Li, Divyesh Thakker, Sarah Ba, et al.
Cell Reports|November 9, 2017
CDK8 Kinase Activity Promotes GlycolysisMatthew D Galbraith, Zdenek Andrysik, Ahwan Pandey, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
Medical Claim Costs of Facioscapulohumeral Muscular Dystrophy in the United StatesAmanda A Hill, June Kinoshita, Mariefel Nicole Deypalan, et al.
Cancer Research|May 19, 2023
Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response PathwayMichael P Ludwig, Matthew D Galbraith, Neetha Paul Eduthan, et al.
Elife|July 30, 2016
Trisomy 21 consistently activates the interferon responseKelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Oncotarget|March 13, 2015
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemiaAlisa B Lee-Sherick, Weihe Zhang, Kelly K Menachof, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the Neurological Sciences|May 14, 2026
Mortality associated with facioscapulohumeral muscular dystrophy: A systematic literature reviewKevin H Li, Divyesh Thakker, Sarah Ba, et al.
Cell Reports|November 9, 2017
CDK8 Kinase Activity Promotes GlycolysisMatthew D Galbraith, Zdenek Andrysik, Ahwan Pandey, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 22, 2026
Medical Claim Costs of Facioscapulohumeral Muscular Dystrophy in the United StatesAmanda A Hill, June Kinoshita, Mariefel Nicole Deypalan, et al.
Cancer Research|May 19, 2023
Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response PathwayMichael P Ludwig, Matthew D Galbraith, Neetha Paul Eduthan, et al.
Elife|July 30, 2016
Trisomy 21 consistently activates the interferon responseKelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
JCI Insight|November 3, 2018
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunityAlisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
Oncotarget|March 13, 2015
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemiaAlisa B Lee-Sherick, Weihe Zhang, Kelly K Menachof, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Pageof 2